Related terms
- Transcranial photobiomodulationtPBM
- Light, usually near-infrared, shone through the scalp and skull toward the brain. It is being studied for memory, stroke, brain injury and mood. How much light actually reaches brain tissue is an active research question.
- In vitro and animal research
- Also called preclinical research. In vitro studies use cells in a dish, and animal studies use laboratory animals. They are useful for exploring mechanisms, but results often do not carry over to people.
Research that mentions parkinson’s disease
45 studies in our archive have this term in the title. The newest are below.
Intranasal Photobiomodulation as a Potential Treatment for Parkinson's Disease: A Randomized Placebo-Controlled Pilot Study
Sham showed a decline in MoCA. These findings suggest that intranasal PBM may be a promising adjunctive therapy for PD; further studies are needed to elucidate mechanisms and optimize treatment protocols.
Morning lighting intervention reduces fatigue and improves sleep in Parkinson disease
When combined with the 20 participants from the prior pilot study, significant improvement in fatigue by 2.8 ± 0.85 points (p = 0.0033) was observed and sleep duration was also significantly increased by 24.7 ± 10.4 min (p = 0.012).
Efficacy and Safety of Photobiomodulation Therapy for Motor Symptoms in Parkinson's Disease: A Systematic Review and Meta-Analysis
PBM appears safe, feasible, and acceptable in PD, but current evidence does not support clinically meaningful motor benefits. Heterogeneous protocols, small samples, and absent target-engagement biomarkers limit definitive interpretation.
Blue light therapy delivered through light glasses improves sleep quality and daytime sleepiness in Parkinson's disease: A randomized trial
ConclusionsBlue light therapy delivered through dedicated glasses appeared to show an improvement in sleep quality and daytime sleepiness in individuals with PD.
Examining the Effects of Bright Light Therapy on Sleep and Resting-State Brain Activity in Parkinson's Disease: A Randomized Crossover Pilot Study
BLT improved excessive daytime sleepiness and reduced tonic RWA relative to control light in PD, but did not lead to detectable alterations in intrinsic activity or FC within a priori hypothesized thalamo-cortical or visual pathways.
Effects of light therapy on sleep and anxiety in Parkinson's disease: A pilot trial
BLT showed greater improvement in daytime sleepiness than DLT, while DLT showed greater reduction in anxiety than BLT.
Read this with care
- This entry is general information, not medical advice. See the disclaimer.
- Definitions are written for readers new to the field and may be simplified. Check the full paper when it matters.
- Found a mistake? Tell us.